Changes in butyrylcholinesterase activity in patients with Alzheimer disease treated with acetylcholinesterase inhibitors

被引：0
|
作者：
Sanchez Morillo, J. [1 ]
Estruch Perez, M. J. [1 ]
Barber Ballester, G. [1 ]
Pertusa Collado, V. [1 ]
机构：
[1] Hosp Univ Dr Peset, Serv Anestesiol & Reanimac, Valencia, Spain
来源：
NEUROLOGIA | 2011年 / 26卷 / 04期
关键词：
SUXAMETHONIUM; EDROPHONIUM; NEOSTIGMINE; THERAPY;
D O I：
10.1016/j.nrl.2010.09.025
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：247 / 248
页数：2
相关论文
共 50 条
  • [1] Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease
    Sáez-Valero, J
    Fodero, LR
    Sjögren, M
    Andreasen, N
    Amici, S
    Gallai, V
    Vanderstichele, H
    Vanmechelen, E
    Parnetti, L
    Blennow, K
    Small, DH
    JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 72 (04) : 520 - 526
  • [2] 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment
    Makhaeva, Galina F.
    Lushchekina, Sofya V.
    Boltneva, Natalia P.
    Serebryakova, Olga G.
    Rudakova, Elena V.
    Ustyugov, Alexey A.
    Bachurin, Sergey O.
    Shchepochkin, Alexander V.
    Chupakhin, Oleg N.
    Charushin, Valery N.
    Richardson, Rudy J.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (21) : 5981 - 5994
  • [3] Do extrapyramidal features in Alzheimer patients treated with acetylcholinesterase inhibitors predict disease progression?
    Brodaty, H.
    Sachdev, P.
    Berman, K.
    Gibson, L.
    Kemp, N. M.
    Cullen, B.
    Burns, A.
    AGING & MENTAL HEALTH, 2007, 11 (04) : 451 - 456
  • [4] Acetylcholinesterase and butyrylcholinesterase glycoforms are biomarkers of Alzheimer's disease
    Saez-Valero, Javier
    Small, David H.
    JOURNAL OF ALZHEIMERS DISEASE, 2001, 3 (03) : 323 - 328
  • [5] Tailored Modeling of Rivastigmine Derivatives as Dual Acetylcholinesterase and Butyrylcholinesterase Inhibitors for Alzheimer's Disease Treatment
    Adeowo, Fatima Y.
    Oyetunji, Tosin P.
    Ejalonibu, Murtala A.
    Ndagi, Umar
    Kumalo, Hezekiel M.
    Lawal, Monsurat M.
    CHEMISTRY & BIODIVERSITY, 2021, 18 (11)
  • [6] Synthesis, molecular docking, acetylcholinesterase and butyrylcholinesterase inhibitory potential of thiazole analogs as new inhibitors for Alzheimer disease
    Rahim, Fazal
    Javed, Muhammad Tariq
    Ullah, Hayat
    Wadood, Abdul
    Taha, Muhammad
    Ashraf, Muhammad
    Qurat-ul-Ain
    Khan, Muhammad Anas
    Khan, Fahad
    Mirza, Salma
    Khan, Khalid M.
    BIOORGANIC CHEMISTRY, 2015, 62 : 106 - 116
  • [7] Acetylcholinesterase Inhibitors and Sleep Architecture in Patients with Alzheimer’s Disease
    Jana R. Cooke
    Jose S. Loredo
    Lianqi Liu
    Matthew Marler
    Jody Corey-Bloom
    Lavinia Fiorentino
    Tamara Harrison
    Sonia Ancoli-Israel
    Drugs & Aging, 2006, 23 : 503 - 511
  • [8] Acetylcholinesterase Inhibitors, AMD, and Alzheimer Disease
    Chen, Yu-Hung
    Wang, Chen
    Kurth, Tobias
    JAMA OPHTHALMOLOGY, 2024, 142 (07)
  • [9] Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease
    Cooke, Jana R.
    Loredo, Jose S.
    Liu, Lianqi
    Marler, Matthew
    Corey-Bloom, Jody
    Fiorentino, Lavinia
    Harrison, Tamara
    Ancoli-Israel, Sonia
    DRUGS & AGING, 2006, 23 (06) : 503 - 511
  • [10] Acetylcholinesterase inhibitors in Alzheimer's disease
    McGleenon, BM
    Dynan, KB
    Passmore, AP
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (04) : 471 - 480
12345